The popular diabetes drug Actos has been prescribed to millions of patients since it hit the market in 1999, but in recent years the medication has also been linked to an increased risk for bladder cancer and other health complications.
The Mobile, Alabama, defective drug attorneys at Long & Long are currently investigating claims from Actos users who developed bladder cancer. Patients who took the higher, 80 milligram daily dose of Actos for longer than 12 months are at a particularly high risk for bladder cancer.
Although bladder cancer can typically be treated when diagnosed early, it also has high rate of recurrence and is potentially deadly if not detected and treated in its initial stages. Bladder cancer is accompanied by symptoms including:
- Abdominal pain
- Back pain
- Blood in the urine
- Frequent urination
- Painful urination
- Urinary tract infection
In addition to bladder cancer, Actos has also been associated with an increased risk for heart failure and diabetic macular edema, a swelling of protein deposits and fluid in the eye, and the leading cause of vision loss in diabetics.
If you were prescribed Actos and developed bladder cancer, please contact the Mobile, Alabama, product liability attorneys at Long & Long for your free case evaluation.